Role of “oncogenic nexus” of CIP2A in breast oncogenesis: how does it work?

Por De, Pradip, Carlson, Jennifer H, Leyland-Jones, Brian, Dey, Nandini
Publicado no Am J Cancer Res (2015)

Wnt-beta-catenin pathway signals metastasis-associated tumor cell phenotypes in triple negative breast cancers

Por De, Pradip, Carlson, Jennifer H., Wu, Hui, Marcus, Adam, Leyland-Jones, Brian, Dey, Nandini
Publicado no Oncotarget (2016)

RAC1 GTP-ase signals Wnt-beta-catenin pathway mediated integrin-directed metastasis-associated tumor cell phenotypes in triple negative breast cancers

Por De, Pradip, Carlson, Jennifer H., Jepperson, Tyler, Willis, Scooter, Leyland-Jones, Brian, Dey, Nandini
Publicado no Oncotarget (2016)

Doubling Down on the PI3K-AKT-mTOR Pathway Enhances the Antitumor Efficacy of PARP Inhibitor in Triple Negative Breast Cancer Model beyond BRCA-ness

Por De, Pradip, Sun, Yuling, Carlson, Jennifer H, Friedman, Lori S, Leyland-Jones, Brian R, Dey, Nandini
Publicado em 2014

Erratum to “Doubling Down on the PI3K-AKTmTOR Pathway Enhances the Antitumor Efficacy of PARP Inhibitor in Triple Negative Breast Cancer Model beyond BRCA-ness” [Neoplasia 16 (2014...

Por De, Pradip, Sun, Yuling, Carlson, Jennifer H., Friedman, Lori S., Leyland-Jones, Brian R., Dey, Nandini
Publicado em 2014

Anti-tumor efficacy of BEZ235 is complemented by its anti-angiogenic effects via downregulation of PI3K-mTOR-HIF1alpha signaling in HER2-defined breast cancers

Por Dey, Nandini, Sun, Yuliang, Carlson, Jennifer H, Wu, Hui, Lin, Xiaoqian, Leyland-Jones, Brian, De, Pradip
Publicado no Am J Cancer Res (2016)

Melanoma Proteoglycan Modifies Gene Expression to Stimulate Tumor Cell Motility, Growth and Epithelial to Mesenchymal Transition

Por Yang, Jianbo, Price, Matthew A., Li, GuiYuan, Bar-Eli, Menashe, Salgia, Ravi, Jagedeeswaran, Ramasamy, Carlson, Jennifer H., Ferrone, Soldano, Turley, Eva A., McCarthy, James B.
Publicado em 2009